Not Virtual Enough: A Virtual Library’s Challenges During the COVID-19 Pandemic

As part of the University of Manitoba Libraries Outreach Services, the Winnipeg Regional Health Authority (WRHA) Virtual Library provides library services to hospitals, health centres, community health agencies, and personal care homes throughout the city of Winnipeg, Manitoba. All services of the WRHA Virtual Library, including the collection, are entirely virtual, though staff are physically located in the University’s health library. In March 2020, shortly after the World Health Organization declared the novel coronavirus disease (COVID-19) pandemic, libraries around the world started closing their doors and staff were required to work from home. The virtual infrastructure of our services and collections required no changes in how our patrons accessed the Virtual Library and a smooth transition was expected, but the sudden shift to working from home revealed gaps. This article discusses the unique experience of the WRHA Virtual Library transitioning to a completely virtual environment, the previous reliance on the University’s physical infrastructure, and the inequities identified between librarians and library technicians.

Download Full-text

Current updates on COVID-19 - A review

International Journal of Novel Trends in Pharmaceutical Sciences ◽

10.26452/ijntps.v10i1.1141 ◽

2020 ◽

Vol 10 (1) ◽

pp. 1-8

Author(s):

Ghotekar D S ◽

Vishal N Kushare ◽

Sagar V Ghotekar

Keyword(s):

World Health Organization ◽

Common Cold ◽

Respiratory Diseases ◽

Gastrointestinal Diseases ◽

Hubei Province ◽

World Health ◽

The World ◽

The Common ◽

Novel Coronavirus ◽

Health Organization

Coronaviruses are a family of viruses that cause illness such as respiratory diseases or gastrointestinal diseases. Respiratory diseases can range from the common cold to more severe diseases. A novel coronavirus outbreak was first documented in Wuhan, Hubei Province, China in December 2019. The World Health Organization (WHO) has declared the coronavirus disease 2019 (COVID-19) a pandemic. A global coordinated effort is needed to stop the further spread of the virus. A novel coronavirus (nCoV) is a new strain that has not been identified in humans previously. Once scientists determine exactly what coronavirus it is, they give it a name (as in the case of COVID-19, the virus causing it is SARS-CoV-2).

Download Full-text

An approach to the understanding of the clinical-etiopathological aspect of COVID-19 (SARS-CoV-2)

International Journal of Research in Pharmaceutical Sciences ◽

10.26452/ijrps.v11ispl1.3094 ◽

2020 ◽

Vol 11 (SPL1) ◽

pp. 862-869

Author(s):

Meena Kumari ◽

Monika Agrawal ◽

Rakesh Kumar Singh ◽

Parameswarappa S Byadgi

Keyword(s):

World Health ◽

Apical Surface ◽

Therapy Assessment ◽

Differentiated Cells ◽

The World ◽

Polarized Epithelia ◽

Well Differentiated ◽

Novel Coronavirus ◽

Health Organization ◽

Epidemiological Characteristics

Currently, the world is facing a health and socioeconomic crisis caused by the novel coronavirus disease COVID-19. On 11 March 2020, the World Health Organization (WHO) has declared this disease as a pandemic. The condition (COVID-19) is an infectious disorder triggered by a newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2. Most of the COVID-19 infected patients will experience mild to moderate respiratory symptoms and recover without any unique therapy. Assessment of the clinical and epidemiological characteristics of SARS-CoV-2 cases suggests the infected patients will not be contagious until the onset of severe symptoms and affects the other organs. Well-differentiated cells of apical airway epithelia communicating with ACE2 were promptly infected to SARS-CoV-2 virus. But the expression of ACE 2 in poorly differentiated epithelia facilitated SARS spike (S) protein-pseudo typed virus entry and it is replicated in polarized epithelia and especially exited via the apical surface. Limiting the transmission of COVID-19 infection & its prevention can be regarded as a hierarchy of controls. In this article, we briefly discuss the most recent advances in respect to aetiology, pathogenesis and clinical progression of the disease COVID-19.

Download Full-text

Treatment Options in COVID-19: The Role of Bioavailable Antiviral Ribonucleoside Analog on NHC in vitro

Journal of Regenerative Biology and Medicine ◽

10.37191/mapsci-2582-385x-2(1)-024 ◽

2020 ◽

Author(s):

Lara Bittmann

Keyword(s):

World Health Organization ◽

Clinical Picture ◽

Treatment Options ◽

World Health ◽

Wuhan City ◽

The World ◽

Novel Coronavirus ◽

Health Organization

On December 31, 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on January 7, 2020 and was provisionally named "2019-nCoV". This new Coronavirus causes a clinical picture which has received now the name COVID-19. The virus has spread subsequently worldwide and was explained on the 11th of March, 2020 by the World Health Organization to the pandemic.

Download Full-text

Critical Insight into the Attributes of Emerging Novel Coronavirus (COVID-19) in India and Across the World

Coronaviruses ◽

10.2174/2666796701999200623172631 ◽

2020 ◽

Vol 1 (1) ◽

pp. 49-56

Author(s):

Gaurav M. Doshi ◽

Hemen S. Ved ◽

Ami P. Thakkar

Keyword(s):

Review Article ◽

World Health ◽

Effective Vaccine ◽

Human Contact ◽

The World ◽

Critical Insight ◽

Novel Coronavirus ◽

Health Organization ◽

Insight Into ◽

Old Drugs

The World Health Organization (WHO) has recently announced the spread of novel coronavirus (nCoV) globally and has declared it a pandemic. The probable source of transmission of the virus, which is from animal to human and human to human contact, has been established. As per the statistics reported by the WHO on 11th April 2020, data has shown that more than sixteen lakh confirmed cases have been identified globally. The reported cases related to nCoV in India have been rising substantially. The review article discusses the characteristics of nCoV in detail with the probability of potentially effective old drugs that may inhibit the virus. The research may further emphasize and draw the attention of the world towards the development of an effective vaccine as well as alternative therapies. Moreover, the article will help to bridge the gap between the new researchers since it’s the current thrust area of research.

Download Full-text

The Pandemic of Novel Coronavirus Disease 2019 (COVID-19): Need for an Immediate Action (Preprint)

10.2196/preprints.19628 ◽

2020 ◽

Author(s):

Mujib Ullah

Keyword(s):

World Health Organization ◽

Large Family ◽

Current Treatment ◽

World Health ◽

New Disease ◽

The World ◽

Novel Coronavirus ◽

Health Organization

UNSTRUCTURED Coronaviruses belong to a large family of viruses. Coronavirus also called COVID-19 is a new disease that has not been previously identified in humans. The World Health Organization has announced that COVID-19 is a pandemic. Currently there is no specific vaccine or treatment for COVID-19. Current treatment for COVID-19 is only supportive (treating the symptoms). There are no antiviral or vaccine options at this time. Therefore, it is time to bring collective efforts to treat or prevent a rapidly evolving pandemic of COVID-19.

Download Full-text

Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies

Viruses ◽

10.3390/v13061145 ◽

2021 ◽

Vol 13 (6) ◽

pp. 1145

Author(s):

Hakimeh Baghaei Daemi ◽

Muhammad Fakhar-e-Alam Kulyar ◽

Xinlin He ◽

Chengfei Li ◽

Morteza Karimpour ◽

...

Keyword(s):

Influenza A ◽

H1n1 Virus ◽

World Health ◽

H1n1 Pandemic ◽

Global Pandemic ◽

First Case ◽

Influenza A H1n1 ◽

The World ◽

Novel Coronavirus ◽

Health Organization

Influenza is a highly known contagious viral infection that has been responsible for the death of many people in history with pandemics. These pandemics have been occurring every 10 to 30 years in the last century. The most recent global pandemic prior to COVID-19 was the 2009 influenza A (H1N1) pandemic. A decade ago, the H1N1 virus caused 12,500 deaths in just 19 months globally. Now, again, the world has been challenged with another pandemic. Since December 2019, the first case of a novel coronavirus (COVID-19) infection was detected in Wuhan. This infection has risen rapidly throughout the world; even the World Health Organization (WHO) announced COVID-19 as a worldwide emergency to ensure human health and public safety. This review article aims to discuss important issues relating to COVID-19, including clinical, epidemiological, and pathological features of COVID-19 and recent progress in diagnosis and treatment approaches for the COVID-19 infection. We also highlight key similarities and differences between COVID-19 and influenza A to ensure the theoretical and practical details of COVID-19.

Download Full-text

Optimizing COVID-19 testing capabilities and clinical management using pathology informatics

JAMIA Open ◽

10.1093/jamiaopen/ooaa055 ◽

2020 ◽

Author(s):

Srikar Chamala ◽

Sherri Flax ◽

Petr Starostik ◽

Kartikeya Cherabuddi ◽

Nicole M Iovine ◽

...

Keyword(s):

Severe Acute Respiratory Syndrome ◽

Clinical Management ◽

World Health ◽

University Of Florida ◽

Pathology Informatics ◽

Large Numbers ◽

The World ◽

Health Organization ◽

The University ◽

Reporting Data

Abstract Coronavirus disease 2019, first reported in China in late 2019, has quickly spread across the world. The outbreak was declared a pandemic by the World Health Organization on March 11, 2020. Here, we describe our initial efforts at the University of Florida Health for processing of large numbers of tests, streamlining data collection, and reporting data for optimizing testing capabilities and superior clinical management. Specifically, we discuss clinical and pathology informatics workflows and informatics instruments which we designed to meet the unique challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing. We hope these results benefit institutions preparing to implement SARS-CoV-2 testing.

Download Full-text

Survey of Radon Concentrations in the University of Granada in Southern Spain

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph18062885 ◽

2021 ◽

Vol 18 (6) ◽

pp. 2885

Author(s):

Irene Calvente ◽

María Isabel Núñez ◽

Rachid Chahboun Karimi ◽

Juan Villalba-Moreno

Keyword(s):

Southern Spain ◽

World Health ◽

Maximal Level ◽

15Th Century ◽

The World ◽

Time Periods ◽

Health Organization ◽

The University ◽

Analyze Data ◽

Radon Concentrations

The objective of this pilot study was to gather and analyze data on radon concentrations in workplaces in three buildings of Granada University (Southern Spain) constructed in different centuries. All measurements were made at basement or ground floor level under normal use conditions except for one space (mineral store), in which measurements were compared between the door closed and open. Measurements were conducted during different time periods between October 2013 and March 2019 with a Radon-Scout PLUS portable Radonmonitor. The duration of continuous recordings at different sites ranged between 42 and 1104 h. Mean accumulated radon concentrations ranged between 12 and 95 Bq/m3, below the maximal level of 300 Bq/m3 set by the World Health Organization (WHO). Relatively high values were recorded in the oldest building (15th century), which was also poorly ventilated. Ventilation appeared to be an important factor in reducing radon levels, especially in areas less exposed to radon, such as Southern Spain.

Download Full-text

COVID-19: implications for NHS Staff

British Journal of Healthcare Assistants ◽

10.12968/bjha.2020.14.4.193 ◽

2020 ◽

Vol 14 (4) ◽

pp. 193-197

Author(s):

Alan Glasper

Keyword(s):

World Health ◽

The Novel ◽

Emeritus Professor ◽

The World ◽

Clinical Environments ◽

Public Health Institutions ◽

Health Institutions ◽

Health Organization ◽

The University

In light of the emergence in China of COVID-19, the novel corona virus, emeritus professor Alan Glasper, from the University of Southampton discusses the role of the World Health Organization and other public health institutions in responding to potential new global pandemics and deliberates on the role of NHS staff in coping with infectious disease in clinical environments.

Download Full-text